George A Ward (George Ward)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Dna Methylation

Immune Response

Circulating Tumor

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

George A Ward, Zhiqiang Zhang, Simone Jueliger, Ilya S Potapov, Matthew P Davis, Adam R Boxall, Jason Taylor, Harold N Keer, Andrea Biondo, John F Lyons, Martin Sims, Tomoko Smyth
Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma. Cancer research communications 4 (6) (2024)
George A Ward, Zhiqiang Zhang, Simone Jueliger, Ilya S Potapov, Matthew P Davis, Adam R Boxall, Jason Taylor, Harold N Keer, Andrea Biondo, John F Lyons, Martin Sims, Tomoko Smyth
Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma. Cancer research communications 4 (6) (2024)
George A Ward, Zhiqiang Zhang, Simone Jueliger, Ilya S Potapov, Matthew P Davis, Adam R Boxall, Jason Taylor, Harold N Keer, Andrea Biondo, John F Lyons, Martin Sims, Tomoko Smyth
Epigenetic priming by hypomethylation enhances the immunogenic potential of tolinapant in T-cell lymphoma. Cancer research communications (2024)
George A Ward, Zhiqiang Zhang, Simone Jueliger, Ilya S Potapov, Matthew P Davis, Adam R Boxall, Jason Taylor, Harold N Keer, Andrea Biondo, John F Lyons, Martin Sims, Tomoko Smyth
Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma. Cancer research communications 4 (6) (2024)
Nicola Ferrari, George A Ward, Christina Gewinner, Matthew P Davis, Simone Jueliger, Harpreet Saini, Joanne Munck, Tomoko Smyth, Roberta Ferraldeschi, Harold Keer, John Lyons, Martin J Sims
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma. Blood advances 5 (20) (2021)